Showing results (71-80 of 216) with videos related to
Sort By:
Pageof 22
Frontiers in Pharmacology|March 3, 2020
Views of European Drug Development Stakeholders on Treatment Optimization and Its Potential for Use in Decision-MakingRobbe Saesen, Stéphane Lejeune, Gianluca Quaglio, et al.The Patient|August 14, 2025
Patients' Needs and Preferences for Cardiac Pacemaker Implantation: A Qualitative Study on Disease and Medical Device Characteristics to Inform a Quantitative Preference StudyAlice Vanneste, Peter Sinnaeve, Isabelle Huys, et al.Mayo Clinic Proceedings. Digital Health|April 10, 2025
Existing Meditation and Breathing Devices for Stress Reduction and Their Incorporated Stimuli: A Systematic Literature Review and Competition AnalysisElisabeth Honinx, Stefanie Broes, Bente Roekaerts, et al.Frontiers in Oncology|December 16, 2022
What matters most to patients with multiple myeloma? A Pan-European patient preference studyRosanne Janssens, Tamika Lang, Ana Vallejo, et al.International Journal of Technology Assessment in Health Care|September 7, 2020
Evaluation of precision medicine assessment reports of the Belgian healthcare payer to inform reimbursement decisionsLaurenz Govaerts, Anouk Waeytens, Walter Van Dyck, et al.Applied Health Economics and Health Policy|August 16, 2022
Applications of Behavioral Economics to Pharmaceutical Policymaking: A Scoping Review with Implications for Best-Value Biological MedicinesYannick Vandenplas, Steven Simoens, Florian Turk, et al.Frontiers in Pharmacology|July 29, 2022
Biosimilar Use and Switching in Belgium: Avenues for Integrated PolicymakingLiese Barbier, Steven Simoens, Paul Declerck, et al.Frontiers in Public Health|January 30, 2026
Orphan medical devices: addressing the regulatory and access gaps in the EU and USSanae Akodad, Baptiste Haon, Lise Rochaix, et al.Communications Medicine|January 7, 2026
Impact of drug repurposing between 1985 and 2024 on pharmaceutical innovationSanae Akodad, Xixian Niu, Berta Secades, et al.Drug Discovery Today|August 24, 2025
Advanced therapy medicinal products are coming of age: A pipeline analysis of the clinical trial landscapeMichiel Vanhaeren, Rik Gijsbers, Walter Van Dyck, et al.Pageof 22